So as I understood there could be a longer lasting effect which meant that the placebo group 2 (Who received DXB-200 1st) may have had a longer lasting effect from DMX-200 Which could explain part of the reason why the difference wasn’t significant.
They need to go through the detailed analysis to understand if this could explain some of the high placebo results.
So as I understood there could be a longer lasting effect which...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.8¢ | 33.5¢ | $1.890M | 5.434M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 123542 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 209895 | 5 |
View Market Depth
| Last trade - 14.19pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.005 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| 35.5¢ | 36.0¢ | 33.5¢ | 3623795 | ||
| Last updated 14.44pm 07/05/2024 ? | |||||
| DXB (ASX) Chart |